Penn Medicine Provider
Gastroenterology
Shivani Umang Thanawala, MD
4.8
(121)
Accepting new patients
Sees patients age 18 and up
Penn Gastroenterology Penn Presbyterian
View 1 additional location

About me

  • Assistant Professor of Clinical Medicine (Gastroenterology)

Education and training

  • Medical School: New York University School of Medicine
  • Residency: New York University - Bellevue Hospital
  • Fellowship: Hospital of the University of Pennsylvania

What my patients think about me

Average Rating
4.8

121 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

June 2025
5.0
5.0
she listened
May 2025
4.0
4.0
knowledgeable
April 2025
5.0
5.0
she is very professional, and she has passion for her patience
April 2025
3.0
3.0
i'm not 100% clear on my path for recovery and it's hard to get in to see this provider she said to come back and see her in 3 months and there's no appointments till september

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Thanawala is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Shaul E, Kennedy KV, Spergel ZC, Daneshdoost S, Mahon M, Thanawala S, Spergel JM, Wilkins B, Ryan MJ, Muir AB Endoscopic and histologic utility of transnasal endoscopy in pediatric eosinophilic esophagitis , J Pediatr Gastroenterol Nutr, 78(5): 2024,1155-1160


Thanawala SU, Klein A, Raval K, Amaro JIF, Beveridge CA, Muir AB, Falk GW, Gonzalez-Hernandez G, Lynch KL Exploring X: barriers to care for eosinophilic esophagitis , Diseases of the Esophagus: 2024


Thanawala SU, Kaplan DE, Falk GW, Beveridge CA, Schaubel D, Serper M, Yang YX. Antibiotic Exposure is Associated With a Risk of Esophageal Adenocarcinoma , Clin Gastroenterol Hepatol, 21(11): 2023,2817-2824


Kahn A, Song K, Dhaliwal L, Thanawala S, Hagen CE, Agarwal S, McDonald NM, Gabre JT, Falk GW, Ginsberg GG, Wolfsen HC, Ramirez FC, Leggett CL, Wang KK, Iyer PG. Long-term outcomes following successful endoscopic treatment of T1 esophageal adenocarcinoma: a multicenter cohort study , Gastrointest Endosc: 2023


Vajravelu RK, Shapiro JM, Thanawala SU, Ni J, Lewis JD, El-Serag HB Risk of post-colonoscopy irritable bowel syndrome in patients with and without antibiotic exposure: A Retrospective Cohort Study , Clin Gastroenterol Hepatol, 20(6): 2022,e1305-22


Beveridge CA, Triggs JR, Thanawala SU, Ahuja NK, Falk GW, Benitez AJ, Lynch KL Can FLIP guide therapy in idiopathic esophagogastric junction outflow obstruction? , Dis Esophagus , 35(4): 2022,077


Thanawala SU, Beveridge CA, Muir AB, Strobel MJ, Westcott-Chavez A, Serper M, Yang YX, Lynch KL Hashing out current social media use in eosinophilic esophagitis , Dis Esophagus, 35(4): 2022,077


Song K, Kahn A, Thanawala S, Agarwal S, McDonald N, Gabre J, Falk G, Ginsberg G, Wolfsen H, Ramirez F, Wang K, Iyer P Long-Term (> 5 Year) Outcomes of Endoscopic Resection for T1 Esophageal Adenocarcinoma: A Multicenter Cohort Study , ACG, 98(5): 2021,713-721


Thanawala SU, Beveridge CA, Muir AB, Strobel MJ, Westcott-Chavez A, Serper M, Yang YX, Lynch KL Hashing Out Current Social Media Use in Eosinophilic Esophagitis , Dis Esophagus: 2021


Thanawala SU, Beveridge C, Muir AB, Strobel MJ, Westcott-Chavez A, Lynch KL Perceptions of COVID-19 in the eosinophilic esophagitis population. , Gastroenterology: 2021